Navigation Links
Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House
Date:10/17/2007

Legislation formally calls for research into treatment, cure for devastating lung disease

WASHINGTON, Oct. 17 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced the passage of important legislation that recognizes the need for research into the cause of idiopathic pulmonary fibrosis (IPF), a deadly lung disease with no known cause, no FDA-approved treatment, or cure and a diseases which claims 40,000 lives a year, the same number as are lost to breast cancer.

House Concurrent Resolution 182 (H. Con. Res. 182) passed by a vote of 414-0. The resolution raises the importance of the urgent need to identify viable treatments and an eventual cure for IPF, a disease that is becoming alarmingly more prevalent in the United States.

"The passage of this legislation is a tremendous benchmark for the IPF community," said Mark Shreve, chief executive officer of the Coalition for Pulmonary Fibrosis. "This effort reaffirms our voice is being heard by Congress. We are especially appreciative of Members of Congress for their support, particularly U.S. Rep. Nathan Deal (R-GA) for introducing the resolution and Rep. Brian Baird (D-WA) and Rep. Mike Castle (R-DE) for their co-sponsorship. We are also grateful to the late Rep. Charlie Norwood and his family for their efforts to help raise awareness of IPF."

In speeches on the House floor, Rep. Baird (D-WA) said, "I want to commend families and friends from the Coalition for Pulmonary Fibrosis who were here a couple of weeks ago on Capitol Hill lobbying in support of this legislation...We would hope that this is a first step. Our hope is that by increasing the awareness of our colleagues here in Congress and of the American public that we can not only increase awareness of the disease but begin work towards actual dedicated funding for this."

Rep. Vito Fossella (R-NY) said, "The purpose of this resolution is to bring awareness to the severity of this devastating
'/>"/>

SOURCE Coalition for Pulmonary Fibrosis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
2. Appeals Against The New Resolution By NICE Increases
3. High Resolution CT Accurately Diagnoses Shin Splints
4. Planning for Good Health Resolutions
5. Recognizing heart risk in dialysis patients
6. Official Criticized For Not Recognizing the Competence of the Consultant Radiologist
7. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
8. Long travel increase pulmonary embolism
9. FDA Approves Remodulin for Pulmonary Hypertension
10. Antipsychotic Drug Linked to Pulmonary Embolism
11. Treating Pulmonary Arterial Hypertension In Children With Viagra
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ter to chill out. Places such as backyard pool, ho...s should be very for cautious and always follow th... avoid facing dangerous situations parents have ta...e pool fences and pool alarms. But in case of spas...
...ho have also been diagnosed as HIV-positive seemed... their health status to others//. The study, the ...ns who work with HIV-positive men who are often un...y, co-workers or others about being diagnosed with...
...rious medical courses offered by unaided medical i...on and research department// of the Punjab governm... other similar medical and paramedical courses. R...nd students have also been invited for a consultat...
...es become inflamed or infected affecting 37 millio...nal surgery//. But now Acclarent has come up with ...volves inflating a small balloon in the sinus cavi...ed as a major breakthrough that offers hope to man...
Other Medicine News:Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Gays Have No Regrets 2Health News:Gays Have No Regrets 3Health News:Provisional Fees For Medical Courses Fixed By Punjab Government 2Health News:Teething Problems of Sinuplasty 2
(Date:8/19/2008)...d to identify molecular,signature of motor neuron ...Newswire/ -- ALS Therapy,Development Institute (AL...biomarker effort using blood samples collected thr... These ongoing projects are part of the,Institute,...sion of genes,and proteins, at the onset of, and t...
(Date:8/19/2008)... -- Vical Incorporated,(Nasdaq: VICL ) today anno...,Institute, a leading European medical university,...Control (SMI), a governmental expert agency, to,ev...ector(R) 2000,needle-free injection system (Biojec...tivalent preventive DNA vaccine against HIV., Pro...
(Date:8/18/2008)...xt time you consider popping a,pill when you have ...eep,instead. A senior psychiatrist at the Scripps ... evidence that taking sleeping pills regularly can...pke, M.D.,s article, based on a compilation of stu... been published in the Journal,of Sleep Research. ...
(Date:8/18/2008)...ife expectancy for people with,Down syndrome, WAS... world of Down,syndrome, ,Mr. C, is a rarity. A re...past 16 years, at seventy, ,Mr. C, has well surpas...own syndrome, currently in the,late fifties, but i..., does,not exhibit clinical symptoms of Alzheimer,...
Breaking Medicine Technology:ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Prescription Sleeping Pill Use Tied to Cancer 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3Flavor and Vitamins on the Go 15161 1Flavor and Vitamins on the Go 15161 2Visiprise Named One of the Top Manufacturing Technology Providers 15158 1Visiprise Named One of the Top Manufacturing Technology Providers 15158 2Honeywell Expands Aclar 28R 29 Production for Pharmaceutical Industry 15155 1Honeywell Expands Aclar 28R 29 Production for Pharmaceutical Industry 15155 2Honeywell Expands Aclar 28R 29 Production for Pharmaceutical Industry 15155 3Barilla 28R 29 Whole Grain Makes Healthy Eating Easy 15152 1Barilla 28R 29 Whole Grain Makes Healthy Eating Easy 15152 2
...latin Phase 1 Colorectal and Prostate Cancer,Trial...TH SAN FRANCISCO, Calif., May 23, 2007 /PRNewswire...iopharmaceutical company,focused on oncology, toda...platin, the Company,s lead product candidate, in p... presented in a poster,session at the 43rd Annual ...
...ve in Improving Symptoms and Urine Flow, With,Long...May 23, 2007 /PRNewswire-FirstCall/ -- Spectrum,Ph...y and efficacy,data for ozarelix, the Company,s dr... hypertrophy (BPH), at the American Urology,Associ...n Center in,Anaheim, California on Tuesday, May 22...
Other Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes.
Inquire
Finntip Filters are ideal for PCR and other amplification methods, or for any work where aerosol contamination might occur. They are designed for pipetting DNA/RNA solutions, infectious materials, la
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote
Medicine Products: